Navigation Links
Express Scripts HealthBridge Pharma & Biotech to Provide Specialty Pharmacy and Specialty Distribution Services for EYLEA™ (aflibercept) Injection
Date:1/4/2012

ST. LOUIS, Jan. 4, 2012 /PRNewswire/ -- Express Scripts now provides services for EYLEA, a product of Regeneron, through its HealthBridge Pharma & Biotech services. CuraScript, a wholly owned subsidiary of Express Scripts and part of the HealthBridge suite of services, will be among a limited number of specialty pharmacies and specialty distributors for EYLEA.

EYLEA (aflibercept) Injection was approved by the Food and Drug Administration on Nov. 18 and is indicated for the treatment of neovascular (wet) age-related macular degeneration (AMD). Macular degeneration is diagnosed as either dry (non-vascular) or wet (vascular) and is a leading cause of blindness in older adults. The wet form usually leads to more serious vision loss.

"With a growing aging population, more and more people are affected by macular degeneration," explains Rob Osborne, Express Scripts senior director, business development, Pharma & Biotech. "HealthBridge Pharma & Biotech is proud to provide services that will help patients get the medication they need to treat this debilitating disease."

About HealthBridge Pharma & Biotech
HealthBridge Pharma & Biotech provides a suite of services offering pharmaceutical and biotech companies a single solution approach to patient care. These services include: CuraScript SP Specialty Pharmacy, CuraScript SD Specialty Distribution, Freedom Fertility Pharmacy, risk evaluation and mitigation strategies (REMS), reimbursement, patient assistance programs, data and sales reporting, enhanced account services, and customized adherence programs.  More information can be found at http://www.TheHealthBridgeSolution.com/.

As a service of HealthBridge Pharma & Biotech, CuraScript Specialty Pharmacy is a wholly owned subsidiary of Express Scripts. CuraScript manages the largest number of exclusive Pharma & Biotech programs in the industry and has been involved in nearly every specialty product launch over the last eight years. CuraScript services more than 1,800 plan sponsors that cover tens of millions of Americans.

CuraScript Specialty Distribution, an Express Scripts subsidiary, is a premier provider of comprehensive distribution solutions for physicians' offices, practices, surgery centers, hospitals and other clinical settings.

About Express Scripts
Express Scripts, Inc. (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, is leading the way toward creating better health and value for patients through Consumerology®, the advanced application of the behavioral sciences to healthcare. This approach is helping millions of members realize greater healthcare outcomes and lowering cost by assisting in influencing their behavior. Headquartered in St. Louis, Express Scripts provides integrated PBM services including network-pharmacy claims processing, home delivery services, specialty benefit management, benefit-design consultation, drug-utilization review, formulary management, and medical and drug data analysis services. The company also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services. More information can be found at http://www.express-scripts.com/ and http://www.consumerology.com/.

Media Contact: Thom Gross
314.684.6321
rtgross@express-scripts.com


'/>"/>
SOURCE Express Scripts
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Express Scripts to Present at the J.P. Morgan Healthcare Conference
2. Over 130 Community Leaders and Organizations Across the Nation Urge Express Scripts To Reach Agreement With Walgreens
3. Generex Announces Airing of Antigen Express Breast Cancer Vaccine Segment on Bloomberg Television
4. Medco Shareholders Approve Merger With Express Scripts
5. The National Urban League and League of United Latin American Citizens Urge Express Scripts to Reach Agreement with Walgreens
6. Nationwide Coalition Responds to Express Scripts CEO Statement: "I Cant Stop Certain Pharmacies From Going Out of Business"
7. Combining Express Scripts and Medco Health Solutions Will Help Protect Americans From the Rising Costs of Prescription Medicine
8. Express Scripts and Medco Save Americans Tens of Billions in Healthcare Costs, New Economic Report Shows
9. National Coalition Continues Fight to Stop the Express Scripts/Medco Merger in Nations Capitol
10. Generex Subsidiary Antigen Express to Present AE37 Cancer Vaccine Phase 2 Clinical Data at 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium
11. Express Scripts, Inc. Announces Pricing of $4.1 Billion Senior Notes Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... , December 5, 2016 PharmaBoardroom today releases ... . ... This report offers companies, investors, policymakers, and stakeholders crucial insight ... of Europe , home to some of the world,s ... pharmaceutical companies in Novartis and Roche, and with a number one ranking ...
(Date:12/5/2016)... and TAIPEI, Taiwan , Dec. 5, 2016 ... treatment ropeginterferon alfa-2b showed non-inferiority to hydroxyurea (HU) in Complete ... better safety and tolerability profile of ropeginterferon alfa-2b versus HU ... and the ongoing long-term follow-up trial CONTINUATION-PV to obtain European ... intends to present this data to the FDA as it ...
(Date:12/4/2016)... Attorney General of Louisiana , Charles ... firm of Kahn Swick & Foti, LLC ("KSF"), announces that ... LCI ). On November 3, ... in Generic-Drug Probe to Be Filed by Year-End," which reported ... two years ago, now spans more than a dozen companies," ...
Breaking Medicine Technology:
(Date:12/5/2016)... ... December 05, 2016 , ... As renowned, board-certified dermatologists, Dr. Sabrina G. Fabi ... patients who do not do their research and undergo cosmetic dermatology treatments from unqualified ... midst of a renaissance and every other month a new treatment or device is ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... CardioQuick Patch® significantly improves the reproducibility and accuracy of placing precordial electrodes with ... , Over the last 60 years, studies have shown that single electrode ...
(Date:12/4/2016)... ... ... James Earl Jones is known for myriad roles on stage and screen, he has ... the forthcoming episodes examines mammogram techniques; a very important part of preventative medicine. , ... detection. Like any other disease, treatments have a much higher chance of success if ...
(Date:12/4/2016)... ... December 04, 2016 , ... Patients who wish to gain ... of a cosmetic procedure known as Carbon Dioxide (C02) Fractional Laser Resurfacing ... age spots, fine lines, uneven coloration, wrinkles, scarring, skin laxity or textural ...
(Date:12/2/2016)... ... 02, 2016 , ... Lori G. Cohen and Sara K. ... at the American Conference Institute’s 21st Drug & Medical Device Litigation Conference , ... of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical Device & Health ...
Breaking Medicine News(10 mins):